Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?

Journal of Neurochemistry

Volumn 68, Issue 5, 1997, Pages 2098-2110

  Ruberg, Merle ^a,b   Brugg, Bernard ^a   Prigent, Annick ^a   Hirsch, Etienne ^a   Brice, Alexis ^a   Agid, Yves ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Apoptosis; cDNA library; Dopaminergic neurons; Mitochondria; Parkinson's disease; Sphingomyelin signaling

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; NERVE GROWTH FACTOR; SPHINGOMYELIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROGLIA; MITOCHONDRIAL RESPIRATION; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA; PARKINSONIA;

EID: 0030898725     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68052098.x     Document Type: Article

References (62)

1. Anglade P., Vyas S., Javoy-Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E. C., and Agid Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. (in press).
2. Attardi G. and Schatz G. (1988) Biogenesis of mitochondria. Annu. Rev. Cell Biol. 4, 289-333.
3. Beal F. (1995) Mitochondrial Dysfunction and Oxidative Damage in Neurodegenerative Diseases. R. G. Landes, Austin, Texas.
4. Bindorff L. A., Birch-Machin M., Cartlidge N. E. F., Parker W. D. Jr., and Turnbull D. M. (1991) Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104, 203-208.
5. Blin O., Desnuelle C., Rascol O., Borg M., Peyro Saint Paul H., Azulay J. P., Billé F., Figarella D., Coulom F. G., Pellissier J. F., Montastruc J. L., Chatel M., and Serratrice G. (1994) Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J. Neurol. Sci. 125, 95-101.
6. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., and Hirsch E. C. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172, 151-154.
7. Bothwell A., Yancopoulos G., and Alt F. W. (1990) Subtractive hybridization techniques, in Methods for Cloning and Analysis of Eukaryotic Genes, pp. 117-137. Jones and Bartlett, Boston.
8. Brennan W. A. Jr., Bird E. D., and Aprille J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
9. Brugg B., Michel P. P., Agid Y., and Ruberg M. (1996) Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66, 733-739.
10. Cardellach F., Marti M. J., Fernandez-Solà J., Marin C., Hoek J. B., Tolosa E., and Urbano-Marquez A. (1993) Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 4, 2258-2262.
11. Chesselet M. F., Weiss L., Wuenschell C., Tobin A. J., and Affolter H.-U. (1987) Comparative distribution of RNAs for glutamic acid decarboxylase tyrosine hydroxylase and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J. Comp. Neurol. 262, 125-140.
12. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 16, 156-159.
13. Cleeter M. J. W., Cooper J. M., and Schapira A. H. V. (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
14. Dugan L. L., Sensi S. L., Canzoniero L. M. T., Handran S. D., Rothman S. M., Lin T.-S., Goldberg M. P., and Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
15. Fearnley J. M. and Lees A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283-2301.
16. Fontaine B., Sassoon D., Buckingham M., and Changeux J. P. (1988) Detection of the nicotine acetylcholine receptor a-subunit mRNA by in situ hybridization and neuromuscular junction and chick striatal muscle. EMBO J. 7, 603-609.
17. Greenlund J. S., Deckwerth T. L., and Johnson E. M. Jr. (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1, 303-315.
18. Hanahan D. and Meselson M. (1980) Plasmid screening at high colony density. Gene 10, 63-67.
19. Hannun Y. A. and Obeid L. M. (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73-77.
20. Hatefi Y. (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 54, 1015-1069.
21. Hattori N., Tanaka M., Ozawa T., and Mizuno Y. (1991) Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30, 563-571.
22. Hennet T., Richter C., and Peterhans E. (1993a) Tumor necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289, 587-592.
23. Hennet T., Bertoni G., Richter C., and Peterhans E. (1993b) Expression of Bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53, 1456-1460.
24. Hevner R. F. and Wong-Riley M. T. T. (1991) Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J. Neurosci. 1, 1942-1958.
25. Hirsch E. C. (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 33 (Suppl. 1), 52-59.
26. Janetsky B., Hauk S., Youdim M. B. H., Riederer P., Jellinger K., Pantucek F., Zöchling R., Boissl K. W., and Reichmann H. (1994) Unaltered aconitase activity but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 169, 126-128.
27. Javoy-Agid F., Hirsch E. C., Dumas S., Duyckaerts C., Mallet J., and Agid Y. (1990) Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 38, 245-253.
28. Ji L., Zhang G., Uematsu S., Akahori Y., and Hirabayashi Y. (1995) Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358, 211-214.
29. Kish S. J., Bergeron C., Rajput A., Dozic S., Mastrogiocomo F., Chang L.-J., Wilson J. M., DiStefano L. M., and Nobrega J. N. (1992) Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776-779.
30. Kolesnick R. and Golde D. W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 7, 325-328.
31. Krige D., Carroll M. T., Cooper J. M., Marsden C. D., and Schapira A. H. V. (1992) Platelet mitochondrial function in Parkinson's disease. Ann. Neurol. 32, 782-788.
32. 67 messenger RNA. Neurology 45, 127-134.
33. Mallet J., Rhyner T. A., Vernier P., and Faucon Biguet N. (1988) Subtractive hybridizations: cloning and identification of specific-transcripts. Embo Practical Course, EMBL, Heidelberg.
34. Mann V. M., Cooper J. M., Javoy-Agid F., Agid Y., Jenner P., and Schapira A. H. V. (1990) Mitochondrial function and parental sex effect in Huntington's disease. Lancer 336, 749.
35. Mann V. M., Cooper J. M., Krige D., Daniel S. E., Schapira A. H. V., and Marsden C. D. (1992) Brain skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115, 333-342.
36. Michel P. P., Vyas S., and Agid Y. (1995) Synergistic differentiation by chronic exposure to cyclic AMP and nerve growth factor renders rat phaeochromocytoma PC12 cells totally dependent upon trophic support for survival. Eur. J. Neurosci. 6, 577-586.
37. Mizuno Y., Shigeno O., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., and Kagawa Y. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
38. Mizuno Y., Ikebe S.-I., Hattori N., Kondo P., Tanaka M., and Ozawa T. (1993) Mitochondrial energy crisis in Parkinson's disease, in Advances in Neurology, Vol. 60: Parkinson's Disease - From Basic Research to Treatment (Narabayashi H., Nagatsu T., Yanagisawa N., and Mizuno Y., eds), pp. 282-287. Raven Press, New York.
39. Mochizuki H., Goto K., Mon H., and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123.
40. Mutsiya E., Bowling A. C., and Beal M. F. (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63, 2179-2184.
41. Nakagawa-Hattori Y., Yoshida H., Kondo T., Mizuno Y., and Horai S. (1992) Parkinson's disease a mitochondrial disorder? J. Neurol. Sci. 107, 29-33.
42. + , a metabolite of the neurotoxin MPTP. Life Sci. 36, 2503-2508.
43. Parker W. D., Boyson S. J., and Parks J. K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol 26, 719-723.
44. Parker W. D. Jr., Parks J., Filley C. M., and Kleinschmidt-DeMasters B. K. (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44, 1090-1096.
45. +) and its analogs with rotenone/piericidin binding site of NADH dehydrogenase. J. Neurochem. 56, 1184-1190.
46. Reichmann H., Florke S., Hebenstreit G., Schrubar H., and Riederer P. (1993) Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease. J. Neurol. 24, 377-380.
47. Reynolds I. J. and Hastings T. G. (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15, 3318-3327.
48. Rhyner T. A., Faucon Biguet N., Berrard S., Borbély A. A., and Mallet J. (1986) An efficient approach for the selective isolation of specific transcripts from complex brain mRNA populations. J. Neurosci. Res. 16, 167-181.
49. Scatton B., Javoy-Agid F., Montfort J. C., and Agid Y. (1984) Neurochemistry of monoaminergic neurons in Parkinson's disease, in Neuropharmacology and Central Nervous System - Therapeutic Aspects (Usdin E. A., Carlsson A., Dahlstrom A., and Engel J., eds), pp. 43-52. Alan R. Liss, New York.
50. Schapira A. H. V. (1995) Nuclear and mitochondrial genetics in Parkinson's disease. J. Med. Genet. 32, 411-414.
51. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., and Marsden C. D. (1990a) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
52. 1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
53. Schapira A. H. V., Cooper J. M., Krige D., Jenner P. J., and Marsden C. D. (1992) Mitochondrial function in Parkinson's disease. Ann. Neurol. 32 (Suppl.), S116-S124.
54. Schoffner J. M. (1995) Mitochondrial defects in basal ganglia diseases. Curr. Opin. Neurol. 8, 474-479.
55. Schoffner J. M., Watts R. L., Juncos J. L., Torroni A., and Wallace D. C. (1991) Mitochondrial oxidative phosphorylation deficits in Parkinson's disease. Ann. Neurol. 32 (Suppl.), S116-S124.
56. Schulze-Osthoff K., Bakker A. C., Vanhaesebroeck B., Jacob W. A., and Fiers W. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 267, 5317-5323.
57. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., and Fiers W. (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12, 3090-3104.
58. Talley A. K., Jewhurst S., Perry S. W., Dollard S. C., Gummurulu S., Fine S. M., New D., Epstein L. G., Gendelman H. E., and Gelbard H. A. (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15, 2359-2366.
59. Vila M., Levy R., Herrero M.-T., Ruberg M., Faucheux B., Obeso J. A., Agid Y., and Hirsch E. C. (1997) Consequence of nigrostriatal denervation on the functioning of the basal ganglia in human and non human primates: an in situ hybridization study of cytochrome oxidase subunit 1 mRNA. J. Neurosci. 17, 765-773.
60. Wong-Riley M. T. T. (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12, 94-101.
61. WyHie A. H., Morris R. G., Smith A. L., and Dunlop D. (1984) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142, 67-77.
62. Young B. D. and Anderson M. L. M. (1988) Quantitative analysis of solution hybridization, in Nucleic Acid Hybridization: A Practical Approach (Hames B. D. and Higgins S. J., eds). pp. 47-72. IRL Press, Oxford.